The Cost of Metastatic Prostate Cancer in the United States.
T Anders OlsenChristopher P FilsonThomas B RichardsDonatus U EkwuemeDavid H HowardPublished in: Urology practice (2022)
The per patient annual health care costs attributable to metastatic prostate cancer are substantial and have increased over time, corresponding to the approval of new oral therapies used in treating metastatic prostate cancer.